Werewolf Therapeutics Inc. (HOWL) NASDAQ
$3.38 -0.09 (-2.59%)
Market Cap: $123.57M
As of 06/07/23 04:30 PM EDT. Market closed.
Werewolf Therapeutics Inc. (HOWL)
NASDAQ
$3.38
-0.09 (-2.59%)
Market Cap: $123.57M
As of 06/07/23 04:30 PM EDT. Market closed.
we are an immuno-oncology company advancing a pipeline of next generation, transformative cancer ... read more
we are an immuno-oncology company advancing a pipeline of next generation, transformative cancer treatments. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
46
Address
.
PRICE CHART FOR WEREWOLF THERAPEUTICS INC
From:
To:
NEWS
KEY STATS
Open
$3.60
Previous Close
$3.47
Days Range
$3.38 - $3.67
52 week range
$1.39 - $7.51
Volume
46,930
Avg. Volume (30 days)
36,002
Market Cap
$123.57M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
35,611,355
Open
$3.60
Previous Close
$3.47
Days Range
$3.38 - $3.67
52 week range
$1.39 - $7.51
Volume
46,930
Avg. Volume (30 days)
36,002
Market Cap
$123.57M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
35,611,355
Open in: 
Open in:
INSIDER TRANSACTIONS FOR WEREWOLF THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | Director | Jan 06, 2023 | Buy | $2.21 | 1,853,000 | 4,095,130 | 5,701,056 | Jan 10, 2023, 05:14 PM |
| Seidel-Dugan Cynthia | Chief Scientific Officer | Jan 12, 2022 | Option Exercise | $2.81 | 39,731 | 111,838 | 164,888 | Jan 14, 2022, 05:58 PM |
| Leonard Reid | Chief Operating Officer | Dec 15, 2021 | Sale | $13.41 | 3,000 | 40,242 | 122,292 | Dec 17, 2021, 04:17 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | May 04, 2021 | Buy | $16.00 | 1,715,000 | 27,440,000 | 3,524,758 | May 06, 2021, 04:31 PM |
| GADICKE ANSBERT | 10% Owner | May 04, 2021 | Buy | $16.00 | 245,000 | 3,920,000 | 6,672,183 | May 06, 2021, 04:19 PM |
| EVNIN LUKE | Director | May 04, 2021 | Buy | $16.00 | 150,799 | 2,412,784 | 4,284,172 | May 06, 2021, 04:19 PM |
| Asanuma Sakae | Director | May 04, 2021 | Buy | $16.00 | 312,500 | 5,000,000 | 2,068,909 | May 04, 2021, 04:31 PM |
| Sphera Global Healthcare Management LP | 10% Owner | May 04, 2021 | Buy | $16.00 | 475,000 | 7,600,000 | 787,997 | May 04, 2021, 01:21 PM |
| Flynn James E | 10% Owner | May 04, 2021 | Buy | $16.00 | 800,000 | 12,800,000 | 2,552,787 | May 04, 2021, 12:34 PM |
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| RA CAPITAL MANAGEMENT, L.P. | Director | 01/06/2023 | 4,095,130 |
| Seidel-Dugan Cynthia | Chief Scientific Officer | 01/12/2022 | 111,838 |
| Leonard Reid | Chief Operating Officer | 12/15/2021 | 40,242 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 05/04/2021 | 27,440,000 |
| GADICKE ANSBERT | 10% Owner | 05/04/2021 | 3,920,000 |
| EVNIN LUKE | Director | 05/04/2021 | 2,412,784 |
| Asanuma Sakae | Director | 05/04/2021 | 5,000,000 |
| Sphera Global Healthcare Management LP | 10% Owner | 05/04/2021 | 7,600,000 |
| Flynn James E | 10% Owner | 05/04/2021 | 12,800,000 |
FUNDS WITH A POSITION IN WEREWOLF THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 6,144,881 | 0.36% | 43.17% | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,597 | 0.00583% | No change | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 129,832 | 0.00004% | No change | Other |
| RENAISSANCE TECHNOLOGIES LLC | 34,100 | 0.00012% | -56.41% | Other |
| BLACKROCK INC. | 38,994 | 0% | 1.18% | Other |
CHANGE IN SHARES OUTSTANDING FOR WEREWOLF THERAPEUTICS INC
STOCK BUYBACKS FOR WEREWOLF THERAPEUTICS INC
Period of Report: 03/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2022
23.21%
2Q
06/30/2022
26.70%
3Q
03/31/2022
26.98%
4Q